Cargando…
Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants
A plant-based heterologous expression system is an attractive option for recombinant protein production because it is based on a eukaryotic system of high feasibility, and low biological risks. Frequently, binary vector systems are used for transient gene-expression in plants. However, plant virus v...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008036/ https://www.ncbi.nlm.nih.gov/pubmed/36914098 http://dx.doi.org/10.1016/j.jviromet.2023.114710 |
_version_ | 1784905666566029312 |
---|---|
author | Andrade, Ikaro Alves de Franca, Luísa Valério Kauffmann, Caterynne Melo Maeda, Matheus Hideki Kihara Koyama, Lucas Hideo Hataka Hamann, Pedro Ricardo Vieira Lopes-Luz, Leonardo Fogaça, Matheus Bernardes Torres Camargo, Brenda Rabello de Ribeiro, Bergmann Morais Bührer-Sékula, Samira Nagata, Tatsuya |
author_facet | Andrade, Ikaro Alves de Franca, Luísa Valério Kauffmann, Caterynne Melo Maeda, Matheus Hideki Kihara Koyama, Lucas Hideo Hataka Hamann, Pedro Ricardo Vieira Lopes-Luz, Leonardo Fogaça, Matheus Bernardes Torres Camargo, Brenda Rabello de Ribeiro, Bergmann Morais Bührer-Sékula, Samira Nagata, Tatsuya |
author_sort | Andrade, Ikaro Alves de |
collection | PubMed |
description | A plant-based heterologous expression system is an attractive option for recombinant protein production because it is based on a eukaryotic system of high feasibility, and low biological risks. Frequently, binary vector systems are used for transient gene-expression in plants. However, plant virus vector-based systems offer advantages for higher protein yields due to their self-replicating machinery. In the present study, we show an efficient protocol using a plant virus vector based on a tobravirus, pepper ringspot virus, that was employed for transient expression of severe acute respiratory syndrome coronavirus 2 partial gene fragments of the spike (named S1-N) and the nucleocapsid (named N) proteins in Nicotiana benthamiana plants. Purified proteins yield of 40–60 µg/g of fresh leaves were obtained. Both proteins, S1-N and N, showed high and specific reactivities against convalescent patients’ sera by the enzyme-linked immunosorbent assay format. The advantages and critical points in using this plant virus vector are discussed. |
format | Online Article Text |
id | pubmed-10008036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100080362023-03-13 Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants Andrade, Ikaro Alves de Franca, Luísa Valério Kauffmann, Caterynne Melo Maeda, Matheus Hideki Kihara Koyama, Lucas Hideo Hataka Hamann, Pedro Ricardo Vieira Lopes-Luz, Leonardo Fogaça, Matheus Bernardes Torres Camargo, Brenda Rabello de Ribeiro, Bergmann Morais Bührer-Sékula, Samira Nagata, Tatsuya J Virol Methods Protocols A plant-based heterologous expression system is an attractive option for recombinant protein production because it is based on a eukaryotic system of high feasibility, and low biological risks. Frequently, binary vector systems are used for transient gene-expression in plants. However, plant virus vector-based systems offer advantages for higher protein yields due to their self-replicating machinery. In the present study, we show an efficient protocol using a plant virus vector based on a tobravirus, pepper ringspot virus, that was employed for transient expression of severe acute respiratory syndrome coronavirus 2 partial gene fragments of the spike (named S1-N) and the nucleocapsid (named N) proteins in Nicotiana benthamiana plants. Purified proteins yield of 40–60 µg/g of fresh leaves were obtained. Both proteins, S1-N and N, showed high and specific reactivities against convalescent patients’ sera by the enzyme-linked immunosorbent assay format. The advantages and critical points in using this plant virus vector are discussed. Elsevier B.V. 2023-05 2023-03-11 /pmc/articles/PMC10008036/ /pubmed/36914098 http://dx.doi.org/10.1016/j.jviromet.2023.114710 Text en © 2023 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Protocols Andrade, Ikaro Alves de Franca, Luísa Valério Kauffmann, Caterynne Melo Maeda, Matheus Hideki Kihara Koyama, Lucas Hideo Hataka Hamann, Pedro Ricardo Vieira Lopes-Luz, Leonardo Fogaça, Matheus Bernardes Torres Camargo, Brenda Rabello de Ribeiro, Bergmann Morais Bührer-Sékula, Samira Nagata, Tatsuya Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants |
title | Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants |
title_full | Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants |
title_fullStr | Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants |
title_full_unstemmed | Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants |
title_short | Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants |
title_sort | practical use of tobravirus-based vector to produce sars-cov-2 antigens in plants |
topic | Protocols |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008036/ https://www.ncbi.nlm.nih.gov/pubmed/36914098 http://dx.doi.org/10.1016/j.jviromet.2023.114710 |
work_keys_str_mv | AT andradeikaroalvesde practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants AT francaluisavalerio practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants AT kauffmanncaterynnemelo practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants AT maedamatheushidekikihara practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants AT koyamalucashideohataka practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants AT hamannpedroricardovieira practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants AT lopesluzleonardo practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants AT fogacamatheusbernardestorres practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants AT camargobrendarabellode practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants AT ribeirobergmannmorais practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants AT buhrersekulasamira practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants AT nagatatatsuya practicaluseoftobravirusbasedvectortoproducesarscov2antigensinplants |